Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
25 participants
OBSERVATIONAL
2012-04-30
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation of a New Sexuality Questionnaire for Patients With Urinary Incontinence or Pelvic Organ Prolapse
NCT01548989
Psychometric Validation of a French Version of the PISQ-R and a New Questionnaire About Sexuality
NCT01632839
Sexual Fonction and Discomfort in Women After Midurethral Sling Surgery, Using PPSSQ
NCT05527665
Materiovigilance After Urinary Incontinence or Prolapse Surgery
NCT03052985
Development and Evaluation of a New Diagnostic Test in Female Urinary Stress Incontinence
NCT01563653
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Step 2: Perform a first set of comprehension tests with a panel of 15 patients.
Step 3: Establish a revised questionnaire.
Step 4: Perform a second series of comprehension tests with a panel of 10 other patients.
Step 5: Determine the final questionnaire.
Step 6: Perform a back-translation (French\> English.
Step 7: Send the final version of the questionnaire and the questionnaire back-translated to the specific committee of the IUGA for final approval.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The study population
Patients suffering from pelvic organ prolapse and/or urinary incontinence and/or fecal incontinence. See inclusion/exclusion criteria.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient must be insured or beneficiary of a health insurance plan
* Patients suffering from pelvic organ prolapse and/or urinary incontinence and/or fecal incontinence.
Exclusion Criteria
* The patient is under judicial protection, under tutorship or curatorship
* The patient does not understand French
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brigitte Fatton, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire de Nîmes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, Gard, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-A00133-40
Identifier Type: OTHER
Identifier Source: secondary_id
LOCAL/2011/BF-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.